on 09 Feb 2024
Last Applicant/ Owned by
MANCHESTER M2 3DE
GB
Serial Number
79186567 filed on 07th Mar 2016
Registration Number
5248111 registered on 25th Jul 2017
Correspondent Address
Washington, DC 20006
UNITED STATES
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Medical and pharmaceutical research services; research and development services in the field of bacteriology; scientific research services for medical purposes in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; chemical research and analysis; advisory services relating to pharmaceutical research; technical project study, namely, scie Read More
Medical services; diagnosis of diseases, namely, medical diagnosis of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical diagnostic services, testing and analysis, namely, medical diagnostic testing, monitoring and reporting services; genetic testing for diagnostics or treatments for medical purposes; medical information services provided on the Internet, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical consultation and information services in the field of medical products, namely, providing information relating to diagnostic, prophylactic and treatment of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical, medicinal and pharmaceutical consultation services; medical advisory services; medical information services, namely, providing medical information; medical analyses for the diagnosis and treatment of people, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing for diagnostic or treatment purposes, namely, medical testing relating to the diagnosis and treatment of people; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of blood and saliva samples; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of samples obtained from patients; Medical testing for diagnostic or treatment purposes, namely, medical laboratory services for the analysis of blood and saliva samples obtained from patients
N/A
N/A
Medical and pharmaceutical research services; research and development services in the field of bacteriology; scientific research services for medical purposes in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; chemical research and analysis; advisory services relating to pharmaceutical research; technical project study, namely, scientific study and research in the field of the prevention, treatment and management of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical research laboratory services; design and development of apparatus for medical diagnostics; computer-assisted diagnostic testing services, namely, diagnostic services in the field of Familiar Hypercholesterolemia, DLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; Scientific laboratory services, namely, preparation of biological samples for research purposes; Scientific laboratory services, namely, preparation of biological samples for use in testing and analysis in research laboratories
N/A
N/A
Surgical, medical, dental and veterinary instruments and apparatus, namely, medical instruments and apparatus for use in a genetic diagnostic kit in the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) procedures; suture materials; instruments and apparatus for medical diagnostics, namely, apparatus for medical diagnostic testing in the fields of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase); automatic analyzers for medical diagnostics, namely, medical diagnostic instruments for the analysis of body fluids; apparatus for diagnostic testing for medical purposes, namely, medical diagnostic apparatus for testing DNA; diagnostic test kits for detecting diseases, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in genetic body fluids testing; apparatus for analyzing DNA in biological samples for medical use; apparatus for collecting samples of body fluids, namely, medical specimen collection devices in the nature of glass slides, cups or bags for the collection of blood or saliva samples; Medical specimen bags for testing purposes, namely, bags for medical use in storing blood or saliva samples; Medical specimen bags for testing purposes, namely, bags for medical use in collecting blood or saliva samples; Sample preparation device for medical diagnostic uses, namely, sample preparation columns for medical use; containers for medical samples, namely, blood and saliva containers for medical purposes; devices for taking samples for medical use, namely, medical devices for obtaining body fluid samples; urine sample testing instruments for medical diagnostics in the nature of medical diagnostic apparatus for testing DNA; containers specially designed for transporting samples containing living human cells; holders for sample containers, namely, specimen cup holders; capillary tubes for samples
N/A
N/A
Diagnostic preparations for medical or veterinary purposes; products, reagents and indicators for medical diagnostics, namely, preparations, reagents and biological indicators for monitoring the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) for medical or veterinary purposes; Diagnostic agents for medical purposes, namely, diagnostic agents for pharmaceutical use; testing materials for medical use, namely, medical diagnostic reagents and assays for testing of body fluids; pharmaceutical and veterinary products, namely, pharmaceutical products for the treatment of Hypercholesterolemia; food supplements for humans or animals; nutraceutical products for therapeutic use and as a dietary supplement, namely, nutraceuticals for the treatment of Hypercholesterolemia and nutraceuticals for use as a dietary supplement; Plasters for medical purposes, namely, material for dressings; disinfectants
N/A
N/A
No 79186567
No Service Mark
No S22396
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
09th Nov 2024 | TOTAL INVALIDATION PROCESSED BY THE IB |
24th Oct 2024 | INVALIDATION PROCESSED |
24th Oct 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
10th Oct 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
09th Feb 2024 | CANCELLED SECTION 71 |
24th Dec 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
25th Jul 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
09th Jul 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
18th Dec 2020 | CHANGE OF OWNER RECEIVED FROM IB |
20th Nov 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |